News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,373 Results
Type
Article (5810)
Company Profile (20)
Press Release (238543)
Section
Business (87624)
Career Advice (470)
Deals (16468)
Drug Delivery (9)
Drug Development (21232)
Employer Resources (32)
FDA (4046)
Job Trends (4547)
News (129697)
Policy (8408)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (336)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16176)
ALS (20)
Alzheimer's disease (312)
Antibody-drug conjugate (ADC) (13)
Approvals (4064)
Artificial intelligence (45)
Autoimmune disease (4)
Automation (2)
Bankruptcy (107)
Best Places to Work (3387)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (66)
Cancer (486)
Cardiovascular disease (24)
Career advice (400)
Career pathing (2)
CAR-T (30)
Cell therapy (105)
Cervical cancer (2)
Clinical research (17729)
Collaboration (180)
Compensation (150)
Complete response letters (3)
COVID-19 (450)
CRISPR (7)
C-suite (95)
Cystic fibrosis (17)
Data (553)
Depression (7)
Diabetes (45)
Diagnostics (2249)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (26)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (42678)
Editorial (1)
Employer branding (6)
Employer resources (33)
Events (40355)
Executive appointments (301)
FDA (4297)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (214)
Gene editing (16)
Generative AI (2)
Gene therapy (46)
GLP-1 (121)
Government (503)
Guidances (16)
Healthcare (5565)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (468)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8392)
IRA (3)
Job creations (1257)
Job search strategy (365)
Kidney cancer (6)
Labor market (4)
Layoffs (107)
Leadership (4)
Legal (2671)
Liver cancer (17)
Lung cancer (54)
Lymphoma (29)
Management (11)
Manufacturing (51)
MASH (27)
Medical device (4296)
Medtech (4298)
Mergers & acquisitions (8293)
Metabolic disorders (121)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (415)
NextGen: Class of 2025 (1792)
Non-profit (789)
Northern California (888)
Now hiring (2)
Obesity (51)
Opinion (31)
Ovarian cancer (17)
Pain (15)
Pancreatic cancer (19)
Parkinson's disease (23)
Partnered (8)
Patents (26)
Patient recruitment (27)
Peanut (5)
People (26350)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5257)
Phase II (7812)
Phase III (6099)
Pipeline (535)
Policy (4)
Postmarket research (658)
Preclinical (2083)
Press Release (67)
Prostate cancer (28)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (68)
Real estate (2011)
Recruiting (9)
Regulatory (5624)
Reports (15)
Research institute (349)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (25)
Series A (27)
Series B (21)
Service/supplier (2)
Sickle cell disease (8)
Southern California (682)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (4)
Startups (1121)
State (1)
Stomach cancer (1)
Supply chain (11)
United States (7196)
Vaccines (57)
Venture capitalists (3)
Webinars (5)
Weight loss (19)
Women's health (1)
Date
Today (46)
Last 7 days (270)
Last 30 days (1007)
Last 365 days (11414)
2025 (2797)
2024 (12202)
2023 (14506)
2022 (20418)
2021 (21838)
2020 (19697)
2019 (14289)
2018 (10999)
2017 (10865)
2016 (9993)
2015 (13151)
2014 (10359)
2013 (8347)
2012 (9039)
2011 (9442)
2010 (9255)
Location
Africa (199)
Alabama (14)
Alaska (2)
Arizona (66)
Arkansas (1)
Asia (12142)
Australia (1663)
California (1867)
Canada (1031)
China (73)
Colorado (86)
Connecticut (95)
Delaware (32)
Europe (25799)
Florida (264)
Georgia (37)
Idaho (23)
Illinois (112)
India (5)
Indiana (74)
Iowa (1)
Japan (70)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (39)
Maryland (215)
Massachusetts (1542)
Michigan (104)
Minnesota (140)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (14)
Nevada (24)
New Hampshire (23)
New Jersey (663)
New Mexico (8)
New York (501)
North Carolina (340)
North Dakota (2)
Northern California (888)
Ohio (55)
Oklahoma (7)
Oregon (3)
Pennsylvania (365)
Puerto Rico (1)
Rhode Island (11)
South America (306)
South Carolina (4)
Southern California (682)
Tennessee (39)
Texas (259)
Utah (60)
Virginia (41)
Washington D.C. (8)
Washington State (166)
West Virginia (2)
Wisconsin (30)
244,373 Results for "sernova corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
January 30, 2025
·
4 min read
Press Releases
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
March 5, 2025
·
2 min read
Press Releases
Sernova Corp. Announces Appointment of New Chief Executive Officer
August 12, 2024
·
5 min read
Press Releases
Sernova Update on Strategic Initiatives
December 3, 2024
·
4 min read
Press Releases
Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
March 10, 2025
·
3 min read
Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company, today announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes (T1D). To date a total of 7 patients across Cohorts 1 and 2 have achieved insulin independence following transplants of human donor islets via Sernova’s proprietary Cell Pouch System™ and a marginal portal vein top up.
June 25, 2024
·
6 min read
Press Releases
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
April 1, 2025
·
4 min read
Press Releases
Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
December 20, 2024
·
3 min read
Press Releases
Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
March 4, 2025
·
3 min read
Press Releases
Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
February 3, 2025
·
3 min read
1 of 24,438
Next
